1. Clinical and hematological findings in alpacas (Vicugna pacos) with and without Candidatus Mycoplasma haemolamae infection.
- Author
-
Wagener MG, Neubert S, Kiene F, Buchallik-Schregel J, Nicolaisen TJ, Bauer BU, von Altrock A, Großmann T, Polifka A, and Ganter M
- Subjects
- Animals, Male, Female, Anemia microbiology, Anemia blood, Anemia veterinary, Anti-Bacterial Agents therapeutic use, Oxytetracycline therapeutic use, Camelids, New World microbiology, Mycoplasma Infections veterinary, Mycoplasma Infections microbiology, Mycoplasma Infections blood, Mycoplasma Infections drug therapy, Mycoplasma Infections diagnosis, Mycoplasma isolation & purification, Mycoplasma genetics
- Abstract
Anemia is a common problem in South American camelids (SACs). Infections with Candidatus Mycoplasma haemolamae (CMh), a cell-wall free, hemotropic bacterium, are often suspected to be an important cause of anemia, as the pathogen infects the erythrocytes and is found in the blood of up to 30% of SACs. The information on the clinical signs of animals infected with this pathogen vary widely. Most infections are clinically inapparent. Treatment is usually carried out with oxytetracycline. A detailed overview of the clinical and hematological findings in 13 alpacas infected with Candidatus M. haemolamae (CMh+), based on patients from our university clinic and comparing those findings with the results of 22 negative alpacas (CMh-) is provided. Assignment to both groups was based on the PCR result. No relevant clinical or hematological differences between CMh+ and CMh- were found, the clinical signs in CMh+ were usually due to comorbidities. The examination of a blood smear alone proved to be insufficient; a PCR test should be carried out to confirm or rule out an infection. A critical review of the need for antibiotic treatment on the basis of a positive test result alone is recommended., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF